Recently, Hong et al. reported that the expression of RNCR3 is increased in the serum of atherosclerosis patients and that RNCR3 overexpression improves proliferation and the production of inflammatory factors, such as IL-6, IL-1β, and TNF-α, in ECs [69]. This evidence concerns the gene IL1B and atherosclerosis.